Kane Biotech, a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms, has developed and patented a new bone tissue regenerating ...

Merck & Co.'s peptides could be undergoing a transformation into oral tablets thanks to a $493 million licensing deal the company inked with Austria-based drug delivery technology maker Cyprumed.

Antimicrobial peptides (AMPs) exhibit broad-spectrum antimicrobial activity, low propensity to induce bacterial resistance, and multifunctional ...

Scientists have developed stable orally available cyclic peptides with a much higher bioavailability than current ones, virtually creating a generation of drugs that can target previously untreatable ...

TB-500's Role in Biotech R&D Growth SHERIDAN, WY / ACCESS Newswire / December 12, 2025 / From 2024 to 2027, biotech R&D ...

Rising adoption of automated and AI-enabled synthesis platforms positions pharmaceutical and biotechnology companies for ...